Literature DB >> 26536344

Very High Intrapartum Fever in Term Pregnancies and Adverse Obstetric and Neonatal Outcomes.

Uri P Dior1, Liron Kogan, Smadar Eventov-Friedman, Moran Gil, Raz Bahar, Zivanit Ergaz, Shay Porat, Ronit Calderon-Margalit.   

Abstract

BACKGROUND: Intrapartum fever is a well-known risk factor for adverse perinatal outcomes. Maternal intrapartum fever ≥39.0°C at term is a rare event during labor, and there is scarce evidence regarding its implications.
OBJECTIVES: To investigate the association between very high intrapartum maternal fever and perinatal outcomes in term pregnancies.
METHODS: A retrospective cohort analysis including 43,560 term, singleton live births in two medical centers between the years 2003 and 2011 was performed. We compared parturients who experienced a maximal intrapartum fever of <38.0°C with two subgroups of parturients who experienced respective maximal fevers of 38.0-38.9°C and ≥39°C. Adjusted risks for adverse perinatal outcomes were calculated by using multiple logistic regression models to control for confounders.
RESULTS: Compared with normal intrapartum temperature, intrapartum fever ≥39.0°C was associated with an extremely elevated risk for neonatal sepsis 16.08 (95% CI: 2.15, 120.3) as well as with low Apgar scores and neonatal intensive care unit admissions (p < 0.001). Additionally, very high intrapartum fever was related to significantly higher risk for operative delivery (p < 0.001).
CONCLUSIONS: Extremely elevated intrapartum fever is an important indicator of severe neonatal morbidity and operative delivery.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2015        PMID: 26536344     DOI: 10.1159/000440938

Source DB:  PubMed          Journal:  Neonatology        ISSN: 1661-7800            Impact factor:   4.035


  8 in total

Review 1.  Management of clinical chorioamnionitis: an evidence-based approach.

Authors:  Agustin Conde-Agudelo; Roberto Romero; Eun Jung Jung; Ángel José Garcia Sánchez
Journal:  Am J Obstet Gynecol       Date:  2020-09-29       Impact factor: 8.661

2.  Time- and dose-dependent correlations between patient-controlled epidural analgesia and intrapartum maternal fever.

Authors:  Bai-Song Zhao; Bing Li; Qing-Ning Wang; Jun-Xiang Jia; Xing-Rong Song
Journal:  BMC Anesthesiol       Date:  2021-01-29       Impact factor: 2.217

Review 3.  Pregnant women with COVID-19: the placental involvement and consequences.

Authors:  Shahrzad Aghaamoo; Kamran Ghods; Mojgan Rahmanian
Journal:  J Mol Histol       Date:  2021-04-19       Impact factor: 3.156

4.  Study on perinatal-related factors of maternity and newborn in parturients with intrapartum fever in part of Eastern China: A cross-sectional study.

Authors:  Yuru Fan; Chong Fan; Pengyuan Mao; Can Rui; Xinyan Wang; Wenwen Hou; Ting Luan; Zhiyong Dong; Ping Li; Shanwu Feng; Xin Zeng
Journal:  J Clin Lab Anal       Date:  2021-11-16       Impact factor: 2.352

5.  Suspected clinical chorioamnionitis with peak intrapartum temperature <380C: the prevalence of confirmed chorioamnionitis and short term neonatal outcome.

Authors:  Anvar Paraparambil Vellamgot; Khalil Salameh; Lina Hussain M Habboub; Rajesh Pattuvalappil; Naser Abulgasim Elkabir; Yousra Shehada Siam; Hakam Khatib
Journal:  BMC Pediatr       Date:  2022-04-11       Impact factor: 2.125

6.  Combined spinal-epidural analgesia and epidural analgesia induced maternal fever with a similar timing during labor-A randomized controlled clinical trial.

Authors:  Qinjun Chu; Yan Sun; Lihui Bai; Yafan Bai; Dongqing Zhang; Ping Zheng; Xiaogao Jin
Journal:  Front Med (Lausanne)       Date:  2022-08-09

7.  Nomogram for perinatal prediction of intrapartum fever: a retrospective case-control study.

Authors:  Zhenfei Jiang; Xiaoyi Hu; Huabei Zeng; Xinghe Wang; Cheng Tan; Chunyan Ni; Lingyun Dai; Su Liu
Journal:  BMC Pregnancy Childbirth       Date:  2021-06-25       Impact factor: 3.007

Review 8.  Obstetrics and Neonatal Outcomes in Pregnant Women with COVID-19: A Systematic Review.

Authors:  Mojdeh Banaei; Vida Ghasemi; Marzieh Saei Ghare Naz; Zahra Kiani; Farzaneh Rashidi-Fakari; Sedigheh Banaei; Behzad Mohammad Souri; Mohsen Rokni
Journal:  Iran J Public Health       Date:  2020-10       Impact factor: 1.429

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.